Documented in an LDA filing dated Apr 20, 2018
Sourced institutional rolesLDA lobbying records
TIFFANI VIVIENNE WILLIAMS
TIFFANI VIVIENNE WILLIAMS appears as a registered lobbyist in federal Lobbying Disclosure Act records connected to organizations tracked by Paper Trail.
Data updated Nov 1, 2026
Source-backed chronology
Career Timeline
Federal LDA filings
Lobbying Activity
CVS HEALTH1st Quarter (Jan 1 - Mar 31) 2018
Registrant: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ · Health Issues
Drug pricing and transparency solutions.
LDA filing ↗CVS HEALTH1st Quarter (Jan 1 - Mar 31) 2020
Registrant: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ · Health Issues
Availability of home dialysis, generally; surprise billing, generally; S. 1895 - Lower Health Care Costs Act, provisions related to surprise billing.
LDA filing ↗CVS HEALTH1st Quarter (Jan 1 - Mar 31) 2021
Registrant: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ · Medicare/Medicaid
Policy and reimbursement changes to the Medicare Advantage program.
LDA filing ↗CVS HEALTH1st Quarter (Jan 1 - Mar 31) 2023
Registrant: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ · Health Issues
Drug pricing proposals, generally; behavioral and mental health, generally; PBM oversight, generally
LDA filing ↗CVS HEALTH1st Quarter (Jan 1 - Mar 31) 2023
Registrant: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ · Medicare/Medicaid
Policy and reimbursement changes to the MA program
LDA filing ↗CVS HEALTH3rd Quarter (July 1 - Sep 30) 2023
Registrant: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ · Health Issues
Drug pricing proposals, generally; behavioral and mental health, generally; PBM oversight, generally; maternal health, generally
LDA filing ↗CVS HEALTH4th Quarter (Oct 1 - Dec 31) 2021
Registrant: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ · Medicare/Medicaid
Policy and reimbursement changes to the MA program
LDA filing ↗CVS HEALTH1st Quarter (Jan 1 - Mar 31) 2022
Registrant: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ · Medicare/Medicaid
Policy and reimbursement changes to the MA program
LDA filing ↗CVS HEALTH3rd Quarter (July 1 - Sep 30) 2022
Registrant: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ · Health Issues
H.R.7213 - Equitable Community Access to Pharmacist Services Act; S.4293 - Pharmacy Benefit Manager Transparency Act of 2022; H.R.5376 - Inflation Reduction Act of 2022, generally
LDA filing ↗CVS HEALTH4th Quarter (Oct 1 - Dec 31) 2021
Registrant: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ · Health Issues
Issues related to COVID-19 testing, and health care coverage; COVID-19 emergency response, in general; drug pricing, in general; home and community-based services, in general; H.R.5376 - Build Back Better Act - provisions related to health care coverage, drug pricing, and taxation; issues related to the 340B program and clinical trials.
LDA filing ↗CVS HEALTH2nd Quarter (Apr 1 - June 30) 2023
Registrant: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ · Health Issues
Drug pricing proposals, generally; behavioral and mental health, generally; PBM oversight, generally; maternal health, generally
LDA filing ↗CVS HEALTH1st Quarter (Jan 1 - Mar 31) 2022
Registrant: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ · Health Issues
Issues related to COVID-19 testing and health care coverage; COVID-19 emergency response, in general; drug pricing, in general; home and community-based services, in general; H.R.5376 - Build Back Better Act - provisions related to health care coverage, drug pricing, and taxation; issues related to the 340B program and clinical trials; S.3799 - PREVENT Pandemics Act, provisions related to pandemic response management.
LDA filing ↗CVS HEALTH3rd Quarter (July 1 - Sep 30) 2015
Registrant: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ · Medicare/Medicaid
S. 275, Medicare Home Infusion Site of Care Act of 2015; Medicare reimbursement for home infusion services, generally
LDA filing ↗CVS HEALTH4th Quarter (Oct 1 - Dec 31) 2015
Registrant: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ · Medicare/Medicaid
S. 275, Medicare Home Infusion Site of Care Act of 2015; Medicare reimbursement for home infusion services, generally
LDA filing ↗CVS HEALTH1st Quarter (Jan 1 - Mar 31) 2016
Registrant: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ · Medicare/Medicaid
S. 275, Medicare Home Infusion Site of Care Act of 2015; Medicare reimbursement for home infusion services, generally
LDA filing ↗CVS HEALTH2nd Quarter (Apr 1 - June 30) 2016
Registrant: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ · Medicare/Medicaid
S. 275, Medicare Home Infusion Site of Care Act of 2015; Medicare reimbursement for home infusion services, generally
LDA filing ↗CVS HEALTH3rd Quarter (July 1 - Sep 30) 2016
Registrant: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ · Health Issues
Moonshot cancer initiative, issues related to prevention.
LDA filing ↗CVS HEALTH3rd Quarter (July 1 - Sep 30) 2016
Registrant: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ · Medicare/Medicaid
S. 275, Medicare Home Infusion Site of Care Act of 2015; Medicare reimbursement for home infusion services, generally
LDA filing ↗CVS HEALTH4th Quarter (Oct 1 - Dec 31) 2016
Registrant: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ · Medicare/Medicaid
S. 275, Medicare Home Infusion Site of Care Act of 2015; Medicare reimbursement for home infusion services, generally; H.R. 6, 21st Century Cures Act, and H.R. 34, 21st Century Cures Act, provisions related to home infusion and ASP.
LDA filing ↗CVS HEALTH4th Quarter (Oct 1 - Dec 31) 2016
Registrant: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ · Health Issues
Moonshot cancer initiative; Senate chronic care bill
LDA filing ↗CVS HEALTH1st Quarter (Jan 1 - Mar 31) 2017
Registrant: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ · Medicare/Medicaid
Medicare reimbursement for home infusion services; S. 637, C-Thru Act.
LDA filing ↗CVS HEALTH2nd Quarter (Apr 1 - June 30) 2017
Registrant: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ · Medicare/Medicaid
Medicare reimbursement for home infusion services.
LDA filing ↗CVS HEALTH3rd Quarter (July 1 - Sep 30) 2017
Registrant: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ · Medicare/Medicaid
Medicare reimbursement for home infusion services.
LDA filing ↗CVS HEALTH4th Quarter (Oct 1 - Dec 31) 2018
Registrant: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ · Health Issues
Drug pricing policy.
LDA filing ↗CVS HEALTH1st Quarter (Jan 1 - Mar 31) 2019
Registrant: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ · Health Issues
Drug pricing policy.
LDA filing ↗CVS HEALTH4th Quarter (Oct 1 - Dec 31) 2019
Registrant: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ · Health Issues
S.1895, Lower Health Care Costs Act, provisions related to pharmacy benefit managers.
LDA filing ↗CVS HEALTH2nd Quarter (Apr 1 - June 30) 2020
Registrant: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ · Health Issues
Availability of home dialysis, generally; surprise billing, generally; S.1895 - Lower Health Care Costs Act, provisions related to surprise billing; interoperability, generally; provisions related to health care coverage and COVID-19 testing, generally.
LDA filing ↗CVS HEALTH3rd Quarter (July 1 - Sep 30) 2020
Registrant: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ · Health Issues
Surprise billing, generally; S. 1895 - Lower Health Care Costs Act, provisions related to surprise billing; provisions related to health care coverage and COVID-19 testing, generally; H.R. 8254, BETTER Kidney Care Act; S. 4574, BETTER Kidney Care Act.
LDA filing ↗CVS HEALTH4th Quarter (Oct 1 - Dec 31) 2020
Registrant: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ · Health Issues
Surprise billing, generally; S.1895 - Lower Health Care Costs Act, provisions related to surprise billing; provisions related to health care coverage and COVID-19 testing, generally; H.R. 133, Coronavirus Response and Relief Supplemental Appropriations Act, 2021, provisions relating to surprise billing and pharmaceutical benefit managers.
LDA filing ↗CVS HEALTH1st Quarter (Jan 1 - Mar 31) 2021
Registrant: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ · Health Issues
H.R.1319, American Rescue Plan Act of 2021, provisions relating to pharmaceutical benefit managers, COVID-19 testing, and health care coverage; COVID-19 emergency response, in general; drug pricing, in general.
LDA filing ↗CVS HEALTH2nd Quarter (Apr 1 - June 30) 2021
Registrant: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ · Medicare/Medicaid
Policy and reimbursement changes to the MA program.
LDA filing ↗CVS HEALTH2nd Quarter (Apr 1 - June 30) 2021
Registrant: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ · Health Issues
Issues related to COVID-19 testing, and health care coverage; COVID-19 emergency response, in general; drug pricing, in general; home and community-based services, in general; American Family Plan and American Jobs Plan, provisions related to health care coverage, drug pricing, and taxation.
LDA filing ↗CVS HEALTH3rd Quarter (July 1 - Sep 30) 2021
Registrant: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ · Medicare/Medicaid
Policy and reimbursement changes to the MA program.
LDA filing ↗CVS HEALTH3rd Quarter (July 1 - Sep 30) 2021
Registrant: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ · Health Issues
Issues related to COVID-19 testing, and health care coverage; COVID-19 emergency response, in general; drug pricing, in general; home and community-based services, in general; H.R.5376 - Build Back Better Act - provisions related to health care coverage, drug pricing, and taxation.
LDA filing ↗CVS HEALTH3rd Quarter (July 1 - Sep 30) 2023
Registrant: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ · Medicare/Medicaid
Issues related to program cuts
LDA filing ↗CVS HEALTH3rd Quarter (July 1 - Sep 30) 2021
Registrant: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ · Budget/Appropriations
S.Con.Res.5 - A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2021 and setting forth the appropriate budgetary levels for fiscal years 2022 through 2030; H.Res.101 - Providing for the adoption of the concurrent resolution (S. Con. Res. 5) setting forth the congressional budget for the United States Government for fiscal year 2021 and setting forth the appropriate budgetary levels for fiscal years 2022 through 2030; H.Con.Res.11 - Establishing the congressional budget for the United States Government for fiscal year 2021 and setting forth the appropriate budgetary levels for fiscal years 2022 through 2030 - provisions related to health care coverage, drug pricing, and taxation.
LDA filing ↗CVS HEALTH4th Quarter (Oct 1 - Dec 31) 2021
Registrant: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ · Budget/Appropriations
S.Con.Res.5 - A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2021 and setting forth the appropriate budgetary levels for fiscal years 2022 through 2030; H.Res.101 - Providing for the adoption of the concurrent resolution (S. Con. Res. 5) setting forth the congressional budget for the United States Government for fiscal year 2021 and setting forth the appropriate budgetary levels for fiscal years 2022 through 2030; H.Con.Res.11 - Establishing the congressional budget for the United States Government for fiscal year 2021 and setting forth the appropriate budgetary levels for fiscal years 2022 through 2030 - provisions related to health care coverage, drug pricing, and taxation.
LDA filing ↗CVS HEALTH2nd Quarter (Apr 1 - June 30) 2022
Registrant: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ · Health Issues
Issues related to COVID-19 testing and health care coverage; COVID-19 emergency response, in general; drug pricing, in general; home and community-based services, in general; H.R.5376 - Build Back Better Act - provisions related to health care coverage, drug pricing, and taxation; issues related to the 340B program and clinical trials; H.R.7213 - Equitable Community Access to Pharmacist Services Act; S.4293 - Pharmacy Benefit Manager Transparency Act of 2022
LDA filing ↗CVS HEALTH2nd Quarter (Apr 1 - June 30) 2022
Registrant: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ · Medicare/Medicaid
Policy and reimbursement changes to the MA program
LDA filing ↗CVS HEALTH2nd Quarter (Apr 1 - June 30) 2022
Registrant: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ · Taxation/Internal Revenue Code
S.1260 - United States Innovation and Competition Act of 2021, provisions relating to research and development tax deductibility and the sale of online goods; H.R.4521 - United States Innovation and Competition Act of 2021, provisions relating to provisions relating to research and development tax deductibility and the sale of online goods.
LDA filing ↗CVS HEALTH3rd Quarter (July 1 - Sep 30) 2022
Registrant: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ · Medicare/Medicaid
Policy and reimbursement changes to the MA program
LDA filing ↗CVS HEALTH4th Quarter (Oct 1 - Dec 31) 2022
Registrant: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ · Budget/Appropriations
H.R.2617 - Consolidated Appropriations Act, 2023 provisions related to telehealth, Medicaid, mental health, and MA.
LDA filing ↗CVS HEALTH4th Quarter (Oct 1 - Dec 31) 2022
Registrant: BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ · Medicare/Medicaid
Policy and reimbursement changes to the MA program
LDA filing ↗